trending Market Intelligence /marketintelligence/en/news-insights/trending/pmoxjpjbpdccuhzav0saza2 content esgSubNav
In This List

Medpace shareholder prices secondary offering of common stock

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Medpace shareholder prices secondary offering of common stock

Medpace Holdings Inc. announced the pricing of a secondary offering of the company's shares.

Investment funds affiliated with Cinven Capital Management (V) General Partner Ltd., a shareholder of the company, are selling 3 million common shares of the Cincinnati-based contract research organization at $42.25 apiece.

The company will not receive any proceeds from the transaction.

Morgan Stanley is acting as the sole book runner in the offering, which is expected to close by June 14.

Cinven Ltd. held 13,399,997 shares of the company as of May 7, representing 35.85% of Medpace, according to S&P Capital IQ data. The shares had a market value of $582.9 million.